149 related articles for article (PubMed ID: 30052808)
21. Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression.
Tsukamoto H; Fujieda K; Hirayama M; Ikeda T; Yuno A; Matsumura K; Fukuma D; Araki K; Mizuta H; Nakayama H; Senju S; Nishimura Y
Cancer Res; 2017 May; 77(9):2279-2291. PubMed ID: 28235765
[TBL] [Abstract][Full Text] [Related]
22. Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance.
Zuliani G; Galvani M; Maggio M; Volpato S; Bandinelli S; Corsi AM; Lauretani F; Cherubini A; Guralnik JM; Fellin R; Ferrucci L
Atherosclerosis; 2010 Nov; 213(1):319-24. PubMed ID: 20869059
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study.
Bonomi A; Veglia F; Baldassarre D; Strawbridge RJ; Golabkesh Z; Sennblad B; Leander K; Smit AJ; Giral P; Humphries SE; Tremoli E; Hamsten A; de Faire U; Gigante B;
Genes Immun; 2020 Feb; 21(2):100-108. PubMed ID: 31932740
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 and soluble interleukin-6 receptor serum levels in recurrent spontaneous abortion women immunized with paternal white cells.
Zenclussen AC; Kortebani G; Mazzolli A; Margni R; Malan Borel I
Am J Reprod Immunol; 2000 Jul; 44(1):22-9. PubMed ID: 10976809
[TBL] [Abstract][Full Text] [Related]
25. The IL-6/IL-6R/sgp130 system and Th17 associated cytokines in patients with gestational diabetes.
Kuźmicki M; Telejko B; Lipińska D; Pliszka J; Wilk J; Wawrusiewicz-Kurylonek N; Zielińska A; Sobota A; Krętowski A; Górska M; Szamatowicz J
Endokrynol Pol; 2014; 65(3):169-75. PubMed ID: 24971916
[TBL] [Abstract][Full Text] [Related]
26. IL-6 as a Mediator of the Association Between Traditional Risk Factors and Future Myocardial Infarction: A Nested Case-Control Study.
Zegeye MM; Andersson JSO; Wennberg P; Repsilber D; Sirsjö A; Ljungberg LU
Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1570-1579. PubMed ID: 33657883
[TBL] [Abstract][Full Text] [Related]
27. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.
Campbell IL; Erta M; Lim SL; Frausto R; May U; Rose-John S; Scheller J; Hidalgo J
J Neurosci; 2014 Feb; 34(7):2503-13. PubMed ID: 24523541
[TBL] [Abstract][Full Text] [Related]
28. Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction.
Groot HE; Al Ali L; van der Horst ICC; Schurer RAJ; van der Werf HW; Lipsic E; van Veldhuisen DJ; Karper JC; van der Harst P
Clin Res Cardiol; 2019 Jun; 108(6):612-621. PubMed ID: 30367209
[TBL] [Abstract][Full Text] [Related]
29. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
[TBL] [Abstract][Full Text] [Related]
30. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage.
Jasiewicz M; Knapp M; Waszkiewicz E; Ptaszynska-Kopczynska K; Szpakowicz A; Sobkowicz B; Musial WJ; Kaminski KA
Cytokine; 2015 Dec; 76(2):187-192. PubMed ID: 26163998
[TBL] [Abstract][Full Text] [Related]
31. Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction.
Ritschel VN; Seljeflot I; Arnesen H; Halvorsen S; Eritsland J; Fagerland MW; Andersen GØ
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412895
[TBL] [Abstract][Full Text] [Related]
32. Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction.
Kaminski KA; Kozuch M; Bonda T; Wojtkowska I; Kozieradzka A; Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Winnicka MM; Musial WJ
Atherosclerosis; 2009 Oct; 206(2):581-7. PubMed ID: 19406401
[TBL] [Abstract][Full Text] [Related]
33. High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption.
Dovio A; Perazzolo L; Saba L; Termine A; Capobianco M; Bertolotto A; Angeli A
Eur J Endocrinol; 2006 May; 154(5):745-51. PubMed ID: 16645023
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 "Trans-Signaling" and Ischemic Vascular Disease: The Important Role of Soluble gp130.
Morieri ML; Passaro A; Zuliani G
Mediators Inflamm; 2017; 2017():1396398. PubMed ID: 28250574
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).
Cesari M; Penninx BW; Newman AB; Kritchevsky SB; Nicklas BJ; Sutton-Tyrrell K; Tracy RP; Rubin SM; Harris TB; Pahor M
Am J Cardiol; 2003 Sep; 92(5):522-8. PubMed ID: 12943870
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory Markers and Outcomes in Kidney Transplant Recipients.
Molnar MZ; Nagy K; Remport A; Tapolyai MB; Fülöp T; Kamal F; Kovesdy CP; Mucsi I; Mathe Z
Transplantation; 2017 Sep; 101(9):2152-2164. PubMed ID: 27798514
[TBL] [Abstract][Full Text] [Related]
37. IL-6 and its receptors in coronary artery disease and acute myocardial infarction.
Anderson DR; Poterucha JT; Mikuls TR; Duryee MJ; Garvin RP; Klassen LW; Shurmur SW; Thiele GM
Cytokine; 2013 Jun; 62(3):395-400. PubMed ID: 23582716
[TBL] [Abstract][Full Text] [Related]
38. Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer.
Won HS; Kim YA; Lee JS; Jeon EK; An HJ; Sun DS; Ko YH; Kim JS
Cancer Invest; 2013 Oct; 31(8):516-21. PubMed ID: 23902164
[TBL] [Abstract][Full Text] [Related]
39. Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes.
Sharma S; Purohit S; Sharma A; Hopkins D; Steed L; Bode B; Anderson SW; Caldwell R; She JX
Mediators Inflamm; 2015; 2015():279393. PubMed ID: 26339132
[TBL] [Abstract][Full Text] [Related]
40. The interleukin-6/interleukin-6-receptor system is activated in donor hearts.
Plenz G; Eschert H; Erren M; Wichter T; Böhm M; Flesch M; Scheld HH; Deng MC
J Am Coll Cardiol; 2002 May; 39(9):1508-12. PubMed ID: 11985915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
